Glial imaging in neuropsychiatric diseases using CB184 and THK 5351

Glial imaging in neuropsychiatric diseases using CB184 and THK 5351 - Glial imaging in neuropsychiatric diseases

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000032007

Enrollment

Registered

2018-04-01

Start date

2018-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neuropsychiatric diseases

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. The subjects who have intention to participate in this study, and signed informed consent. 2. Male and female subjects of >=20 and <90 years, old. 3. The subjects who were diagnosed with a neuropsychiatric disease

Exclusion criteria

Exclusion criteria: 1. The subjects who cannnot undergo MRI scan. 2. The subject who have chronic dysfunction in the organs. 3. Pregnant or woman who has a chance of pregnant. 4. The subjects who were judged by the clinical investigator to be inappropriate as a participant in this study.

Design outcomes

Primary

Measure	Time frame
measurement of CB184 and THK5351 bindings	—

Countries

Japan

Contacts

Public Contactkenji Ishibashi

Tokyo Metropolitan Institute of Gerontology Research Team for Neuroimaging

ishibashi@pet.tmig.or.jp03-3964-3241

Outcome results